Skip to content
Catalyst

resveratrolFinding

Resveratrol decreases interleukin‑6 concentration

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“A significant reduction of IL-6 concentration was observed only in the patients receiving ≥500 mg/day dose of resveratrol (WMD = -1.89 pg/ml, 95% CI = -3.73 to -0.05, P = 0.04) with inter-study heterogeneity (I2 = 94.4%, P < 0.001).”
Quoted verbatim from Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.
This finding among the 87 findings on its endpoint

resveratrol

Interleukin-6 concentration

lowers

Effect as reported

CI −3.73 to −0.05

Who
Adults with inflammatory disease receiving ≥500 mg/day resveratrol (dose subgroup, one of 26 studies on IL-6 per Methods); the abstract does not report a significant result for the overall/lower-dose population.
Dose studied
≥500 mg/day (dose-stratified subgroup)

Very limited evidencePMID 34303665 · 2021

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3R2HN600AF1TNCQAQK3CW34